D
Daniel Truong
Researcher at University of California, Riverside
Publications - 28
Citations - 335
Daniel Truong is an academic researcher from University of California, Riverside. The author has contributed to research in topics: Botulinum toxin & Dystonia. The author has an hindex of 7, co-authored 28 publications receiving 211 citations. Previous affiliations of Daniel Truong include University of California & Orange Coast Memorial Medical Center.
Papers
More filters
Journal ArticleDOI
Levodopa-induced dyskinesia: clinical features, incidence, and risk factors.
TL;DR: The prevalence of LID mainly depends on age at onset, disease duration, and severity, and duration of levodopa therapy, and some of the risk factors for the development of dyskinesia are modifiable.
Journal ArticleDOI
The nosology of tardive syndromes
TL;DR: The term tardive dyskinesia is proposed to be used to refer to the original description of repetitive and complex oral-buccal-lingual (OBL) movements, as well as to the analogous repetitive movements that can appear in the limbs, trunk, or pelvis.
Journal ArticleDOI
Dystonia and Tremor: A Cross-Sectional Study of the Dystonia Coalition Cohort.
Aasef G. Shaikh,Sinem Balta Beylergil,Laura Scorr,Gamze Kilic-Berkmen,Alan Freeman,Christine Klein,Johanna Junker,Sebastian Loens,Norbert Brüggemann,Alexander Münchau,Tobias Bäumer,Marie Vidailhet,Emmanuel Roze,Cecilia Bonnet,Joseph Jankovic,Joohi Jimenez-Shahed,Neepa Jayant Patel,Laura Marsh,Cynthia Comella,Richard L. Barbano,Brian Berman,Irene A. Malaty,Aparna Wagle Shukla,Stephen G. Reich,Mark S. LeDoux,Alfredo Berardelli,Gina Ferrazzano,Natividad Stover,William G. Ondo,Sarah Pirio Richardson,Rachel Saunders-Pullman,Zoltan Mari,Pinky Agarwal,Charles H. Adler,Sylvain Chouinard,Susan H. Fox,Allison Brashear,Daniel Truong,Oksana Suchowersky,Samuel Frank,Stewart A. Factor,J. Perlmutter,Hyder Azad Jinnah +42 more
TL;DR: The large number of cases evaluated by an international team of movement disorder experts facilitated the dissection of several important factors that influence the apparent prevalence and phenomenology of tremor in dystonia.
Journal ArticleDOI
Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations
TL;DR: Treatment with the three types of botulinum toxin currently commercially available – Botox®, Dysport® and Myobloc®/NeuroBloc® is described.